Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932538 | 1.00 | NTRK1 (0.85) | NTRK1JAK2 | |
| SCHEMBL22073625 | 1.00 | NTRK1 (0.85) | NTRK1JAK2 | |
| SCHEMBL932537 | 1.00 | NTRK1 (0.85) | NTRK1JAK2 | |
| SCHEMBL24120995 | 0.92 | NTRK1 (0.82) | NTRK1JAK2 | |
| SCHEMBL22073668 | 0.92 | NTRK1 (0.82) | NTRK1JAK2 | |
| SCHEMBL2691801 | 0.92 | NTRK1 (1.00) | NTRK1JAK2 | |
| SCHEMBL2691800 | 0.92 | NTRK1 (1.00) | NTRK1JAK2 | |
| SCHEMBL29794653 | 0.92 | NTRK1 (1.00) | NTRK1JAK2 | |
| SCHEMBL29497124 | 0.91 | NTRK1 (0.72) | NTRK1JAK2 | |
| SCHEMBL29450115 | 0.91 | NTRK1 (0.72) | NTRK1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023083362-A1 | DRUG FOR TREATING TUMORS | 石药集团中奇制药技术（石家庄）有限公司 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023055952-A1 | NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) DEGRADING COMPOUNDS | C4 THERAPEUTICS, INC. (US) | 2023-04-06 | — | — | WO | disclosed |
| CN-115551863-A | Salt form, crystal form, pharmaceutical composition and application of tyrosine kinase inhibitor | 贝达药业股份有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-114315899-A | 3- (aromatic benzimidazolyl) pyrazolopyrimidine derivative and application thereof | 上海美迪西生物医药股份有限公司 | 2022-04-12 | — | — | CN | disclosed |